抗氧化剂添加的G系列培养基与标准培养基对同胞卵母细胞胚胎发育及妊娠结局的前瞻性随机多中心比较
该前瞻性随机多中心研究比较了含三种抗氧化剂(A3:乙酰左旋肉碱、N-乙酰半胱氨酸和α-硫辛酸)的G系列培养基与标准G系列培养基对同胞卵母细胞胚胎发育和妊娠潜力的影响。共纳入两个IVF中心的133名患者的1563个中期II卵母细胞,评估第3天胚胎和第5/6天囊胚质量及临床结局。结果显示,在35-40岁患者中,抗氧化剂组显著提高种植率和持续妊娠率。
要点
- 在35-40岁患者中,含A3的培养基显著提高种植率(胎囊57.5% vs 23.5%,胎心50.0% vs 23.5%)和持续妊娠率(50% vs 25.8%)。
- 整体人群中,A3组第3天优质胚胎比例显著高于对照组(50.2% vs 40.7%)。
- 抗氧化剂补充可能通过减少氧化应激改善人胚胎在辅助生殖技术中的活力。
核心结论
- 在35-40岁患者中,IVF和胚胎培养过程中添加抗氧化剂可显著提高种植率和妊娠率。
研究设计与样本
- 前瞻性随机多中心比较同胞卵母细胞研究,纳入两个IVF中心的133名患者共1563个中期II卵母细胞。
主要发现
- 第3天优质胚胎率:G系列组40.7%,G系列加A3组50.2%(P < 0.05)。
- 胎囊种植率:G系列组39.2%,G系列加A3组50.6%;胎心种植率:G系列组37.8%,G系列加A3组47.1%。
- 35-40岁患者胎囊种植率:G系列组23.5%,A3组57.5%(P < 0.05);胎心种植率:G系列组23.5%,A3组50.0%(P < 0.05)。
- 35-40岁患者持续妊娠率:A3组50%,对照组25.8%(P < 0.05)。
关键数值与推荐
- 第3天优质胚胎定义为8-10个细胞、细胞均匀且碎片少;优质囊胚定义为3BB或以上。
- 临床结局评估基于第5天新鲜或玻璃化复苏囊胚移植。
临床怎么用
- 对于35-40岁接受辅助生殖技术的患者,可考虑在IVF和胚胎培养中使用含抗氧化剂(A3)的培养基以改善妊娠结局。
局限性
- 研究未报告其他年龄段患者的详细分层结果,且样本来自两个中心,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does the inclusion of three antioxidants (A3), acetyl-l-carnitine (ALC), N-acetyl-l-cysteine (NAC) and alpha-lipoic acid (ALA) improve human embryo development and pregnancy potential? DESIGN: Prospective randomized multicentre comparison of sibling oocytes. A total of 1563 metaphase II oocytes from 133 patients in two IVF centres. Day 3 embryo and day 5/6 blastocyst quality were assessed. Good embryo quality on day 3 was defined as 8 to 10 cells with even cells and low fragmentation; good quality blastocysts as 3BB or greater. Clinical outcome was assessed on transfers of fresh or vitrified-warmed blastocyst on day 5. RESULTS: Of the two-pronuclei, 40.7% (G-Series) and 50.2% (G-Series with A3 group) resulted in good quality embryos on day 3 (P < 0.05). The implantation rate by fetal sac was 39.2% and 50.6%, and by fetal heartbeat was 37.8% and 47.1% for the G-Series and G-Series with A3 group, respectively. When stratified by female patient age, patients 35-40 years had an implantation rate by fetal sac and heart of 23.5% in the G-Series compared with 57.5% (P < 0.05) and 50.0% (P < 0.05) in the A3 group. The ongoing pregnancies in patients 35-40 years were significantly higher in the A3 group (50%) compared with the control (25.8%) (P < 0.05). CONCLUSIONS: The presence of antioxidants during IVF and embryo culture for patients 35-40 years resulted in a significant increase in implantation and pregnancy rate. Supplementation of antioxidants to IVF and culture media may therefore improve the viability of human embryos in assisted reproductive technologies, plausibly through the reduction of oxidative stress.
引用
- Gardner DK, Kuramoto T, Tanaka M, et al. Prospective randomized multicentre comparison on sibling oocytes comparing G-Series media system with antioxidants versus standard G-Series media system. Reprod Biomed Online. 2020. PMID: 32299733. doi:10.1016/j.rbmo.2020.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。